mai 9, 2023 Policy Analysis Guttmacher Expert Testimony in Support of Approving Over-the-Counter Status for Opill Without an Age Restriction
avril 10, 2023 Policy Analysis Anti-Abortion Judge Attempts to Ban Mifepristone Nationwide, Ignoring Science and More Than Two Decades of the Drug’s Safe Use in the United States
mars 2, 2023 Policy Analysis Just the Numbers: The Impact of US International Family Planning Assistance, 2022
février 7, 2023 Policy Analysis 10 US States Would Be Hit Especially Hard by a Nationwide Ban on Medication Abortion Using Mifepristone